2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (4393):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-76030
    Nortropinone hydrochloride
    		98.0%
    Nortropinone hydrochloride is a derivative of Tropinone (HY-Y0135). Nortropinone hydrochloride is an important pharmaceutical intermediate for the synthesis of other active compounds.
    Nortropinone hydrochloride
  • HY-W014785
    1,4-Diphenylbuta-1,3-diyne
    		99.97%
    1,4-Diphenylbuta-1,3-diyne (Compound 2a) is a synthetic symmetrical 1,3-diene derivative. 1,4-Diphenylbuta-1,3-diyne exhibits significant selective anti-proliferative activity against HeLa cells. 1,4-Diphenylbuta-1,3-diyne can be utilized in cervical cancer research.
    1,4-Diphenylbuta-1,3-diyne
  • HY-131092A
    H-Asn-Arg-OH diTFA
    		99.83%
    H-Asn-Arg-OH diTFA is a dipeptide formed by the connection of asparagine and arginine via a peptide bond, which can be used in polypeptide synthesis.
    H-Asn-Arg-OH diTFA
  • HY-W019738
    1,1'-Dibromoferrocene
    		99.53%
    1,1'-Dibromoferrocene is a drug synthesis intermediate that can be used to synthesize a wide number of 1,2-disubstituted ferrocenes.
    1,1'-Dibromoferrocene
  • HY-W014217
    7-Aminodeacetoxycephalosporanic acid
    		98.0%
    7-Aminodeacetoxycephalosporanic acid (7-ADCA) is a key intermediate in the synthesis of cephalosporins.
    7-Aminodeacetoxycephalosporanic acid
  • HY-160897
    Methoxy-PEG2000-C3-amide-C2-Mal
    		99.69%
    Methoxy-PEG2000-C3-amide-C2-Mal can bind to hemoglobin through the 93Cys residue to produce di-PEGylated hemoglobin.
    Methoxy-PEG2000-C3-amide-C2-Mal
  • HY-100062
    2,4-Dibromo-5-nitropyridine
    2,4-Dibromo-5-nitropyridine is a trisubstituted pyridine derivative used to prepare Rho kinase inhibitors.
    2,4-Dibromo-5-nitropyridine
  • HY-178078
    PTX-SS-COOH
    PTX-SS-COOH is the proform that can be grafted to the sulfhydryl modified gelatin to form the redox sensitive amphiphilic polymer. The nanoparticle (BSA/Gel-SS-PTX/PTX-SS-COOH NPs) demonstrates an excellent anticancer efficiency. PTX-SS-COOH can be applied in the research of targeted delivery for solid tumors (such as breast cancer and melanoma) by utilizing the unique characteristics of the tumor microenvironment (high GSH level).
    PTX-SS-COOH
  • HY-W318305
    CCT-010354
    		99.10%
    CCT-010354 (Compound 63e) is an agent intermediate that can be used to synthesize PPARα/δ dual agonist.
    CCT-010354
  • HY-W008753
    Z-L-Val-OH
    		99.79%
    Z-L-Val-OH (N-Cbz-L-valine) is an amino acid derivative and key intermediate in organic synthesis. Z-L-Val-OH can be used in the synthesis of anti-cytomegalovirus compounds and peptide inhibitors of human spleen plasminogen activator (SFP) and human leukocyte elastase-like protease (ELP) .
    Z-L-Val-OH
  • HY-W010255S
    Phenylglyoxylic acid-d5
    		99.90%
    Phenylglyoxylic acid-d5 (Benzoylformic acid-d5) is a deuterium labeled Phenylglyoxylic acid (HY-W010255). Phenylglyoxylic acid (Benzoylformic acid) is a metabolite of ethylbenzene and styrene (EB/S) and can be used as a biomarker of exposure to EB/S in human. Phenylglyoxylic acid can be used as drug intermediate for synthesis of antineoplastic compounds.
    Phenylglyoxylic acid-d<sub>5</sub>
  • HY-128753
    D-Lyxose
    		98.0%
    D-Lyxose is an endogenous metabolite. D-Lyxose is a rare pentose with significant potential for pharmaceutical synthesis. D-Lyxose serves as a starting material for antitumor agents (such as α-galactosylceramide-based immunostimulants). D-Lyxose acts as a precursor for L-nucleoside analogs used in the development of antiviral drugs. D-Lyxose can be used as a synthetic intermediate for other rare sugars (such as L-ribose).
    D-Lyxose
  • HY-W005596
    5-Bromo-3-fluoropicolinic acid
    		99.85%
    5-Bromo-3-fluoropicolinic acid (5-Bromo-3-fluoropyridine-2-carboxylic acid) is a drug synthesis intermediate that can be used to synthesize an inhibitor of glycinamide ribonucleotide formyltransferase.
    5-Bromo-3-fluoropicolinic acid
  • HY-75261
    Paliperidone impurity 15
    Paliperidone impurity 15 is an impurity of Paliperidone.
    Paliperidone impurity 15
  • HY-W009688
    Dibutyl maleate
    		99.19%
    Dibutyl maleate, the diester of the Maleic Acid, can be used as an intermediate of pharmaceutical synthesis. Dibutyl maleate can enhance contact sensitization to Fluorescein isothiocyanate in mice.
    Dibutyl maleate
  • HY-402737
    FTC-146 precursor
    		98.87%
    FTC-146 precursor (Compound s6) is a drug intermediate that can be used to prepare σ-1 receptor positron emission tomography tracers ([¹⁸F]FTC-146).
    FTC-146 precursor
  • HY-W017167
    Pyrrolidin-2-yl-acetic acid hydrochloride
    		99.82%
    Pyrrolidin-2-yl-acetic acid hydrochloride is the precursor for the biosynthesis of Tussilagine (HY-N1388) and Isotussilagine. Pyrrolidin-2-yl-acetic acid hydrochloride can be used in neurological research.
    Pyrrolidin-2-yl-acetic acid hydrochloride
  • HY-N3994
    16α,17α-Epoxyprogesterone
    		99.22%
    16α,17α-Epoxyprogesterone is an important steroid, serving as an intermediate for many hormonal drugs such as Hydrocortisone (HY-N0583) and Megestrol (HY-B1834). 16α,17α-Epoxyprogesterone can further biotransform into another significant intermediate, 11α-hydroxy-16α,17α-epoxyprogesterone, to manufacture additional compounds.
    16α,17α-Epoxyprogesterone
  • HY-W012637
    3-Acetylaniline
    		99.97%
    3-Acetylaniline (3'-Aminoacetophenone) is a drug intermediate that can be used for the synthesis of quinoline derivatives.
    3-Acetylaniline
  • HY-109033
    Fosmetpantotenate
    		98.05%
    Fosmetpantotenate is a phosphopantothenic acid (PPA) precursor designed to release PPA intracellularly, leading to restoration of CoA levels. Fosmetpantotenate is used to research pantothenate kinase-associated neurodegeneration.
    Fosmetpantotenate